Delivery Order SPE2DB20D3103-SPE2DB23FN3X1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.96 firm fixed-price delivery order covers the supply of PILOCARPINE 1% EYE DROPS 15ML, a critical pharmaceutical product, with a completion date of March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, SPE2DB20D7059|SPE2DB25FQFL0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4568087786 - PILOCARPINE 1% EYE DROPS 15ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,932.16 and a performance period extending through May 2, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.72 firm fixed-price delivery order is for the supply of 4567796080 PILOCARPINE 1% EYE DROPS 15ML. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PILOCARPINE 1% EYE DROPS 15ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on February 28, 2025, with a ceiling value of $1,245.00 and a completion date of March 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award does not have a set-aside designation, indicating...
- This federal contract award, valued at $1,244.45, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Pilocarpine 2% Eye Drops, a critical medical commodity, to support military healthcare programs and facilities. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,030.94, is for the delivery of Pilocarpine 4% eye drops, 15 mL, and has an ultimate completion date of April 15, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. No set-aside was used for this award. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery...
- This is a $1,553.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Pilocarpine 2% eye drops, a specialty medication used to treat certain eye conditions. The contract has an ultimate completion date of March 17, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. Both...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a Delivery Order contract valued at $2,032.32 by the Defense Logistics Agency (DLA) to provide PILOCARPINE 2% EYE DROPS 15ML. The contract has a completion date of September 28, 2023. Amerisourcebergen Drug Corp is the prime contractor on this firm fixed price contract, which does not have a set-aside designation. The company also holds an Indefinite Delivery Contract (IDC) with DLA valued up to...
- This federal contract award, with ID SPE2DX15D6044|SPE2DX24FCRAT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,604.11 firm fixed-price delivery order is for the supply of 4% pilocarpine eye drops in 15mL bottles. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Pilocarpine 4% eye drops, 15ML. The contract has a total ceiling value of $1,067.90 and is a firm fixed price contract. It was awarded on August 23, 2024, with an ultimate completion date of August 26, 2024. The contract is not associated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN3X1Delivery Order
This federal contract award, valued at $1,016.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560924528 – PILOCARPINE 2% EYE DROPS 15ML, a pharmaceutical product, with a completion date of May 15, 2023. This is a firm fixed-price delivery order contract, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 5/12/23 |